DORM
Dorman Products, Inc. Consumer Cyclical - Auto Parts Investor Relations →
Dorman Products, Inc. (DORM) closed at $101.98 as of 2026-03-20, trading 2.8% below its 200-week moving average of $104.88. This places DORM in the below line zone. The stock is currently moving closer to the line, down from -2.0% last week. With a 14-week RSI of 23, DORM is in oversold territory.
A big spike in selling this week — 2.3x the usual volume, and the price dropped. Sometimes this kind of heavy selling marks the end of a decline. The idea is that the last reluctant holders have finally sold, leaving fewer sellers left to push the price lower.
Over the past 1779 weeks of data, DORM has crossed below its 200-week moving average 29 times. On average, these episodes lasted 16 weeks. Historically, investors who bought DORM at the start of these episodes saw an average one-year return of +13.8%.
With a market cap of $3.1 billion, DORM is a mid-cap stock. The company generates a free cash flow yield of 0.4%. Return on equity stands at 14.7%. The stock trades at 2.1x book value.
Over the past 33.2 years, a hypothetical investment of $100 in DORM would have grown to $6688, compared to $2683 for the S&P 500. That represents an annualized return of 13.5% vs 10.4% for the index — confirming DORM as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been growing at a 170.9% compound annual rate, with 4 consecutive years of positive cash generation. A business generating more cash every year while trading below its 200-week moving average is exactly the kind of disconnect value investors look for.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: DORM vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After DORM Crosses Below the Line?
Across 28 historical episodes, buying DORM when it crossed below its 200-week moving average produced an average return of +16.6% after 12 months (median +19.0%), compared to +20.7% for the S&P 500 over the same periods. 68% of those episodes were profitable after one year. After 24 months, the average return was +30.8% vs +43.3% for the index.
Each line shows $100 invested at the moment DORM crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
DORM has crossed below its 200-week MA 29 times with an average 1-year return of +13.8% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| May 1992 | Mar 1993 | 43 | 41.8% | +9.1% | +6101.5% |
| May 1993 | May 1993 | 1 | 0.4% | -3.6% | +5990.8% |
| Mar 1994 | Apr 1994 | 2 | 9.4% | -10.7% | +5990.8% |
| Apr 1994 | Jun 1995 | 59 | 26.5% | -14.3% | +5990.8% |
| Oct 1995 | Aug 1996 | 40 | 19.8% | +14.3% | +5990.8% |
| Sep 1996 | Sep 1996 | 1 | 1.4% | +16.9% | +5681.1% |
| Sep 1996 | Oct 1996 | 1 | 3.4% | +19.0% | +5780.8% |
| Dec 1996 | Dec 1996 | 3 | 6.9% | +28.0% | +5681.1% |
| Mar 1997 | Mar 1997 | 2 | 3.0% | +40.0% | +5584.7% |
| Apr 1997 | Apr 1997 | 2 | 4.5% | +83.1% | +5681.1% |
| May 1997 | Jun 1997 | 1 | 1.1% | +75.0% | +5584.7% |
| Sep 1998 | Oct 1998 | 6 | 23.4% | -29.2% | +5147.5% |
| Dec 1998 | Mar 1999 | 13 | 10.3% | -42.3% | +5147.5% |
| Apr 1999 | Jun 1999 | 12 | 18.1% | -55.2% | +5780.8% |
| Aug 1999 | Dec 2001 | 123 | 76.7% | -67.9% | +4990.8% |
| Jan 2008 | Jul 2008 | 26 | 34.8% | -20.3% | +1818.8% |
| Sep 2008 | Dec 2008 | 11 | 27.0% | +25.1% | +1728.3% |
| Jan 2009 | Mar 2009 | 11 | 41.1% | +48.4% | +1914.9% |
| Apr 2009 | Apr 2009 | 1 | 3.9% | +91.6% | +1845.1% |
| Jan 2016 | Feb 2016 | 5 | 6.4% | +67.9% | +143.9% |
| Jul 2019 | Aug 2019 | 1 | 1.2% | +18.2% | +47.4% |
| Aug 2019 | Aug 2019 | 1 | 0.0% | +15.5% | +45.0% |
| Nov 2019 | Nov 2019 | 1 | 0.8% | +31.6% | +42.0% |
| Jan 2020 | Jul 2020 | 26 | 36.5% | +30.1% | +46.1% |
| Aug 2022 | Nov 2022 | 11 | 11.0% | -3.5% | +16.7% |
| Dec 2022 | Jan 2023 | 5 | 9.5% | -13.5% | +17.9% |
| Mar 2023 | Mar 2024 | 54 | 25.3% | +8.8% | +22.2% |
| Apr 2024 | Jul 2024 | 13 | 3.7% | +24.2% | +13.2% |
| Mar 2026 | Ongoing | 2+ | 2.8% | Ongoing | -0.8% |
| Average | 16 | — | +13.8% | — |
Frequently Asked Questions
Is DORM below its 200-week moving average?
Yes. As of 2026-03-20, Dorman Products, Inc. (DORM) is trading 2.8% below its 200-week moving average of $104.88. The current price is $101.98.
What is DORM's 200-week moving average price?
Dorman Products, Inc.'s 200-week moving average is $104.88 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when DORM drops below its 200-week moving average?
DORM has crossed below its 200-week moving average 29 times in our data. On average, buying at that moment produced a one-year return of +13.8%. These dips have historically been decent entry points. These episodes lasted 16 weeks on average.
Is DORM a good value right now?
Here's what our data says about DORM as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 23 (oversold). Free cash flow yield is 0.4%. Return on equity is 14.7%. Price-to-book is 2.1x. This is not a buy or sell recommendation — always do your own research.
How does DORM compare to the S&P 500?
Over the past 33.2 years, $100 invested in DORM would have grown to $6688, compared to $2683 for the S&P 500. That's 13.5% annualized vs 10.4% for the index. DORM has outperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20